Exhibit 1.01
GlaxoSmithKline plc
Conflict Minerals Report
For the Year Ended December 31, 2018
This report for the year ended December 31, 2018 has been prepared by GlaxoSmithKline plc (together with its consolidated subsidiaries, “GSK”) and is submitted in accordance with Rule 13p-1 under the Securities Exchange Act of 1934 (the “Rule”), and regulations and guidance issued by the Securities and Exchange Commission (“SEC”) relating to the Rule. The Rule requires certain disclosures if a reporting company manufactures or contracts to manufacture products for which one or more of the following minerals are necessary to the functionality or production of the company’s products: cassiterite; columbite-tantalite (coltan); and wolframite; their derivatives tantalum, tin, and tungsten; and gold (collectively, “3TGs”). These are considered “conflict minerals” under the Rule regardless of their geographic origin and whether or not they fund armed conflict in the Democratic Republic of the Congo or its neighboring countries (the “covered countries”).
This report is available on our website at https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/.
1. Company Overview and Use of 3TGs
GSK is a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Our manufacturing network currently includes 76 sites in over 35 countries. We also partner with a network of over 260 external contract manufacturing organizations (“CMOs”) that supply finished products for sale and distribution by GSK. Product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. GSK obtains (i) materials from suppliers for manufacturing purposes and (ii) finished products from CMOs for sales and distribution by GSK.
Pursuant to the Rule, as further described below, we conducted in good faith a technical review of GSK’s products and surveyed our suppliers and CMOs. This review and survey was updated via ongoing monitoring for calendar year 2018 to determine whether 3TGs were present in our products.
GSK’s ongoing monitoring of materials provided by our suppliers covered by the Rule (“In Scope Suppliers”) and of products supplied by our CMOs and covered by the Rule, for which GSK “contracted to manufacture the products,” (as that term is used in the Rule) (“In Scope CMOs”) and the 3TGs declarations provided by such In Scope Suppliers and In Scope CMOs indicate that, for calendar year 2018, (i) three suppliers (the “Applicable Suppliers”) provided us with materials containing 3TGs for manufacturing purposes for the products that we manufacture and (ii) eight CMOs (the “Applicable CMOs”) provided us with products that contained 3TGs that were necessary to the functionality or production (both the CMO products that we purchase and the products that we manufacture that contain 3TGs are the “2018 covered products”).
2. Reasonable Country of Origin Inquiry
We then conducted in good faith a reasonable country of origin inquiry (“RCOI”) that GSK believes was reasonably designed to determine whether any 3TGs necessary to the functionality or production of our 2018 covered products originated in the covered countries and were not from recycled or scrap sources.
1
Some 3TGs declarations from Applicable Suppliers and Applicable CMOs that indicated the materials or products they provided to GSK contained 3TGs also indicated that these 3TGs did not come from the covered countries. Where the source of the 3TGs was unclear from the 3TGs declarations, we sent the Applicable Suppliers and Applicable CMOs the Conflict Minerals Reporting Template (“CMRT”), available through the Responsible Minerals Initiative (“RMI”) or otherwise followed up with them, requesting information regarding the source of the 3TGs in the materials or products they provided to GSK. For the calendar year 2018, two Applicable Suppliers provided unclear responses to our RCOI and we are continuing to follow up with them, however we have no reason to believe that such suppliers sourced any 3TGs from the covered countries. All of the remaining Applicable Suppliers and Applicable CMOs but one indicated to us that any 3TGs contained in materials or products they provided to GSK did not come from the covered countries. One of the Applicable CMOs indicated that some of the 3TGs contained in the product they provide to GSK, a smoking cessation device, originated in the covered countries.
Due to the source of the 3TGs contained in the products from this one CMO, we concluded from our RCOI that we have reason to believe that some of the 3TGs necessary to the functionality or production of our 2018 covered products originated in the covered countries and were not from recycled or scrap sources. GSK therefore conducted further due diligence on the source and chain of custody of the necessary 3TGs contained in the 2018 covered products.
3. Design of Due Diligence Process
GSK’s due diligence measures were designed to conform with the framework set forth in the OECD Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas: Third Edition (the “OECD Guidance”) and the related supplements for gold and for tin, tantalum and tungsten. Below is a description of the measures that GSK implemented and the diligence we performed.
4. Description of Due Diligence Performed
The due diligence measures we performed are presented below according to the five-step framework established by the OECD.
4.1 Establish Strong Company Management Systems
Internal Management Structure
GSK has a 3TGs Compliance Programme, sponsored by our Chief Financial Officer, that follows the OECD Guidance. It includes a Steering Committee, which monitors compliance with our 3TG policies and our annual reporting obligations. GSK’s Procurement Organisation is responsible for implementing our 3TGs compliance strategy and GSK’s senior management is briefed about the results of our due diligence efforts on a regular basis.
System of Controls and Transparency
GSK has a Third Party Oversight (“TPO”) Standard Operating Procedure that covers the process for managing and identifying risk when GSK engages a third party to provide goods or services. This procedure involves a risk assessment, including questions relating to the presence of 3TGs in any products or materials provided to GSK by a third party. Following this risk assessment, the person responsible for the contract with the relevant third party must also follow the applicable business units’ procedures relating to 3TGs (the “3TGs Programme”) to facilitate compliance with our disclosure obligations under the Rule. Upon adoption of the Rule, we undertook a review of all materials provided by our In Scope Suppliers and products provided by our In Scope CMOs to determine whether 3TGs were present in accordance with the 3TGs Programme.
2
As discussed above, we monitor and evaluate the materials provided by In Scope Suppliers and the products provided by In Scope CMOs to identify whether these materials or products contain 3TGs. We update our technical review of the materials and products and request 3TGs declarations from In Scope Suppliers and In Scope CMOs concerning the presence of 3TGs in the materials or products they supply to GSK as needed. The 3TGs declarations explain GSK’s reporting obligations under the Rule and require the In Scope Supplier or In Scope CMO to confirm that they have taken reasonable steps to assess whether the materials or products supplied to GSK contains 3TG. Where any 3TGs declarations do not confirm that any identified 3TGs in these materials or products either do not come from the covered countries or do come from recycled or scrap sources, GSK sends those remaining In Scope Suppliers and In Scope CMOs a CMRT questionnaire, or otherwise contacts the supplier or CMO to obtain further information.
Whenever a new supplier or CMO is added to the GSK network, the person responsible for the contract must conduct a third-party risk assessment as part of the TPO process and determine whether the materials or products supplied fall within the scope of the Rule and contain 3TGs. If so, the person responsible for the contract must follow the RCOI procedures outlined above. In addition, if an existing In Scope Supplier or In Scope CMO introduces new materials or products into our network, or if the composition of existing materials or products are altered, the person responsible for the contract must determine if the modified materials or products contain 3TGs and, if they do, follow the procedures outlined above.
Supply Chain Engagement
We expect our suppliers, our CMOs and their respective suppliers to exercise due diligence around the source and chain of custody of 3TGs used in materials or products they supply to us and this expectation is communicated to such parties through our public policy statement on working with third parties and our Conflict Minerals Statement (as defined below). Any existing suppliers or CMOs sourcing 3TGs in a manner that benefits armed groups in the covered countries are contractually obligated to identify alternative sources; a failure to do so will result in termination of the applicable supply agreement. Any new or renewed supply agreements entered into by GSK with suppliers and CMOs seek confirmation that any 3TGs supplied to GSK do not benefit armed groups in the covered countries.
Grievance Mechanism
We have longstanding grievance mechanisms for employees, suppliers and CMOs to report potential concerns or violations of GSK policies, including our policies regarding 3TGs. These mechanisms include direct reporting to an employee’s line manager, Human Resources, Global Ethics and Compliance, or Legal representative. Alternatively, concerns or violations may be reported using telephone, internet or postal reporting channels. These channels are managed independently of GSK, are available globally and allow for reports to be kept anonymous if the local laws and regulations permit it.
Communication
GSK maintains a public statement describing in detail its position regarding 3TGs and its procedures for addressing 3TGs issues (the “GSK Conflict Minerals Statement”). GSK’s company statement relating to 3TGs is available at: https://www.gsk.com/media/4859/conflict-minerals.pdf.
3
4.2 Identify and Assess Risk in the Supply Chain
As discussed above, we monitor the materials provided by In Scope Suppliers and In Scope CMOs that provide GSK with materials or products to determine whether such materials or products contain 3TGs. We review the 3TGs declarations that we receive to determine if the response is complete or if further engagement with the supplier or CMO is required and also follow-up with any non-responsive suppliers or CMOs. We then request that any suppliers or CMOs that supply GSK with materials or products that contain 3TGs to complete the CMRT, provide a certification that any 3TGs necessary to the functionality or production of the product are either not sourced from the covered countries or are from scrap or recycled sources, or otherwise confirm, to the extent possible, the source of the 3TGs in the materials or products provided to GSK.
For 2018, we reviewed any CMRTs or certifications provided to assess the reasonableness of the responses and to determine, to the extent possible, the country of origin of the 3TGs contained in the 2018 covered products. An important component of our supplier and CMO survey process, and an element of the CMRT, is the identification of the smelters and refiners that process the 3TGs used in our products. The CMRT was developed by the RMI, which is an initiative founded by members of the Electronic Industry Citizenship Coalition and the Global e-Sustainability Initiative. The Responsible Minerals Assurance Process (“RMAP”) of the RMI uses an independent third-party audit to identify smelters and refiners that have systems in place to assure sourcing of only 3TGs not benefitting armed groups in the covered countries.
For 2018, we reviewed a list of all smelters and refiners identified by any suppliers or CMOs that reported any of the 3TGs contained in the materials or products supplied to GSK are sourced from the covered countries to determine if such smelters or refiners had been validated under the RMAP as “conformant” with the RMAP assessment protocols (“RMAP conformant”). We also reviewed the list of smelters and refiners against information provided by other independent third party audit programs, such as the London Bullion Market Association’s Responsible Gold Program.
4.3 Design and Implement a Strategy to Respond to Risks
GSK’s strategy to respond to identified risks in the supply chain includes reviewing supplier and CMO responses to our above described inquiries for certain red flags. These include the following:
| • | The supplier or CMO does not respond to our request despite follow ups. |
| • | The supplier or CMO provides an incomplete response to our inquiry, or provides inconsistent data within a CMRT or an unclear certification. |
| • | The supplier or CMO reports that it supplies GSK with materials or products that contain 3TGs that may be sourced from the covered countries, but it has not identified all of the smelters or refiners its supply chain for such materials or products. |
| • | A smelter or refiner is not listed with the RMI. |
We address incomplete, inconsistent or otherwise unsatisfactory responses received from our suppliers or CMOs or a lack of response through an escalation process. This process involves an initial follow up to our original request, and then if the matter is still unresolved it is escalated through the Steering Committee.
4
We evaluate our relationships with suppliers and CMOs on an ongoing basis, and one factor that we take into account is the extent to which we believe a supplier or CMO has failed to reasonably comply with our policies and expectations.
We maintain a tracker to document and monitor compliance with our 3TGs Programme and the results of the procedures described in this report. The tracker is reviewed on a regular basis to check if effective monitoring is taking place and our buying and sourcing processes, which include our procedures relating to 3TGs, are periodically audited. The 3TGs Programme and its effectiveness are reviewed on an annual basis.
The results of these procedures, including a list of any suppliers or CMOs with respect to which an RCOI was conducted and the results of the RCOI and subsequent due diligence, are presented to management on a regular basis and the 3TGs Steering Committee on an annual basis.
4.4 Carry out Independent Third Party Audit of Smelters/Refiners Due Diligence Practices
GSK does not have direct relationships with smelters or refiners and does not perform or specify audits of those entities upstream in its supply chain. Instead, GSK relies on information collected and provided by independent third-party audit program, such as the RMAP and the London Bullion Market Association’s Responsible Gold Program.
4.5 Report on Supply Chain Due Diligence
This Conflict Minerals Report, which constitutes our report on our due diligence, is filed with the SEC, and is available on our website at the following link at https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/.
5. Determination
We seek reasonable information about 3TGs smelters and refiners and the mines or locations of origin of 3TGs in our supply chain by reviewing and implementing best practices established in the OECD and other due diligence implementation programs and requesting our suppliers to complete the CMRT, and evaluating supplier responses as described above. We do not directly source 3TGs from smelters, nor do we have direct knowledge of the country of origin and chain of custody of 3TGs in our supply chain. We must therefore rely on our direct suppliers and CMOs for information relating to the source of any 3TGs in the materials and products supplied to us. These suppliers and CMOs in turn must similarly rely on their own suppliers for such information. Based on our due diligence efforts, we do not have sufficient information to conclusively determine the country of origin of all the 3TGs contained in the materials or products supplied to GSK.
For the year ended December 31, 2018, we identified three Applicable Suppliers and 8 Applicable CMOs that provided materials or products that contained 3TGs. Two of these Applicable Suppliers provided unclear responses and we are continuing to follow up with them. However, we have no reason to believe that such suppliers sourced 3TGs from the covered countries. All of the remaining Applicable Suppliers and Applicable CMOs but one responded that either the materials or products they supply to GSK do not contain 3TGs or that the 3TGs contained in the products supplied to GSK do not originate from the covered countries.
5
This one CMO reported that it received information regarding the source of the 3TGs in the product supplied to GSK from 16 of 21 suppliers, and these suppliers indicated that some of the 3TGs in their respective supply chains are sourced from the covered countries. However, since some of the CMO’s suppliers provide sourcing information on their company-wide supply chain, rather than on the 3TGs actually contained in materials supplied to this CMO, we are unable to trace the chain of custody of any 3TGs specifically contained in our product further up the supply chain to a specific smelter or, in turn, to the mine of origin. Using the data provided by such CMO, and cross-checking against existing RMI smelter lists and London Bullion Market Association’s Responsible Gold Program, we were able to confirm that all but one of the 250 smelters identified as being in their supply chain by this CMO’s suppliers are either currently RMAP conformant or were RMAP conformant until they ceased operations. The country locations of the RMAP conformant identified smelters are listed in Annex I. The one non-RMAP conformant gold smelter (Samduck Precious Metals) is located in the Republic of Korea. We continue to follow up with this CMO regarding the five suppliers that did not provide sourcing information.
GSK is continuing to work with its suppliers and CMOs regarding responsible sourcing practices generally and 3TGs supply chain in particular. We continue to follow up and work with the suppliers that provided unclear responses to our diligence inquiries. Additionally, we intend to encourage any suppliers or CMOs that source 3TGs from smelters that are not RMAP conformant to transition to only sourcing from RMAP conformant smelters.
In accordance with the Rule, this Report has not been audited.
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements made by GSK, including those made in this Report, are subject to risks and uncertainties that may cause actual outcomes to differ materially from those discussed.
6
ANNEX I
| Metal | Smelter/Refiner Facility Name | Location of Facility |
| Gold | Advanced Chemical Company | UNITED STATES OF AMERICA |
| Gold | Aida Chemical Industries Co., Ltd. | JAPAN |
| Gold | Al Etihad Gold LLC | UNITED ARAB EMIRATES |
| Gold | Allgemeine Gold-und Silberscheideanstalt A.G. | GERMANY |
| Gold | Almalyk Mining and Metallurgical Complex (AMMC) | UZBEKISTAN |
| Gold | AngloGold Ashanti Corrego do Sitio Mineracao | BRAZIL |
| Gold | Argor-Heraeus S.A. | SWITZERLAND |
| Gold | Asahi Pretec Corp. | JAPAN |
| Gold | Asahi Refining Canada Ltd. | CANADA |
| Gold | Asahi Refining USA Inc. | UNITED STATES OF AMERICA |
| Gold | Asaka Riken Co., Ltd. | JAPAN |
| Gold | AU Traders and Refiners | SOUTH AFRICA |
| Gold | Aurubis AG | GERMANY |
| Gold | Bangko Sentral ng Pilipinas (Central Bank of the Philippines) | PHILIPPINES |
| Gold | Boliden AB | SWEDEN |
| Gold | C. Hafner GmbH + Co. KG | GERMANY |
| Gold | CCR Refinery - Glencore Canada Corporation | CANADA |
| Gold | Cendres + Metaux S.A. | SWITZERLAND |
| Gold | Chimet S.p.A. | ITALY |
| Gold | Daejin Indus Co., Ltd. | KOREA, REPUBLIC OF |
| Gold | DSC (Do Sung Corporation) | KOREA, REPUBLIC OF |
| Gold | DODUCO Contacts and Refining GmbH | GERMANY |
| Gold | Dowa | JAPAN |
| Gold | Eco-System Recycling Co., Ltd. | JAPAN |
| Gold | Emirates Gold DMCC | UNITED ARAB EMIRATES |
| Gold | OJSC Novosibirsk Refinery | RUSSIAN FEDERATION |
| Gold | Geib Refining Corporation | UNITED STATES OF AMERICA |
| Gold | HeeSung Metal Ltd. | KOREA, REPUBLIC OF |
| Gold | Heimerle + Meule GmbH | GERMANY |
| Gold | Heraeus Metals Hong Kong Ltd. | CHINA |
| Gold | Heraeus Precious Metals GmbH & Co. KG | GERMANY |
| Gold | Inner Mongolia Qiankun Gold and Silver Refinery Share Co., Ltd. | CHINA |
| Gold | Ishifuku Metal Industry Co., Ltd. | JAPAN |
| Gold | Istanbul Gold Refinery | TURKEY |
| Gold | Italpreziosi | ITALY |
| Gold | Japan Mint | JAPAN |
| Gold | Jiangxi Copper Co., Ltd. | CHINA |
| Gold | JSC Uralelectromed | RUSSIAN FEDERATION |
| Gold | JX Nippon Mining & Metals Co., Ltd. | JAPAN |
7
| Gold | Kazzinc | KAZAKHSTAN |
| Gold | Kennecott Utah Copper LLC | UNITED STATES OF AMERICA |
| Gold | Kojima Chemicals Co., Ltd. | JAPAN |
| Gold | Korea Zinc Co., Ltd. | KOREA, REPUBLIC OF |
| Gold | Kyrgyzaltyn JSC | KYRGYZSTAN |
| Gold | LS-NIKKO Copper Inc. | KOREA, REPUBLIC OF |
| Gold | Marsam Metals | BRAZIL |
| Gold | Materion | UNITED STATES OF AMERICA |
| Gold | Matsuda Sangyo Co., Ltd. | JAPAN |
| Gold | Metalor Technologies (Hong Kong) Ltd. | CHINA |
| Gold | Metalor Technologies (Singapore) Pte., Ltd. | SINGAPORE |
| Gold | Metalor Technologies (Suzhou) Ltd. | CHINA |
| Gold | Metalor Technologies S.A. | SWITZERLAND |
| Gold | Metalor USA Refining Corporation | UNITED STATES OF AMERICA |
| Gold | Metalurgica Met-Mex Penoles S.A. De C.V. | MEXICO |
| Gold | Mitsubishi Materials Corporation | JAPAN |
| Gold | Mitsui Mining and Smelting Co., Ltd. | JAPAN |
| Gold | MMTC-PAMP India Pvt., Ltd. | INDIA |
| Gold | Moscow Special Alloys Processing Plant | RUSSIAN FEDERATION |
| Gold | Nadir Metal Rafineri San. Ve Tic. A.S. | TURKEY |
| Gold | Nihon Material Co., Ltd. | JAPAN |
| Gold | Ogussa Osterreichische Gold- und Silber-Scheideanstalt GmbH | AUSTRIA |
| Gold | Ohura Precious Metal Industry Co., Ltd. | JAPAN |
| Gold | OJSC "The Gulidov Krasnoyarsk Non-Ferrous Metals Plant" (OJSC Krastsvetmet) | RUSSIAN FEDERATION |
| Gold | PAMP S.A. | SWITZERLAND |
| Gold | Planta Recuperadora de Metales SpA | CHILE |
| Gold | Prioksky Plant of Non-Ferrous Metals | RUSSIAN FEDERATION |
| Gold | PT Aneka Tambang (Persero) Tbk | INDONESIA |
| Gold | PX Precinox S.A. | SWITZERLAND |
| Gold | Rand Refinery (Pty) Ltd. | SOUTH AFRICA |
| Gold | Republic Metals Corporation | UNITED STATES OF AMERICA |
| Gold | Royal Canadian Mint | CANADA |
| Gold | SAAMP | FRANCE |
| Gold | Safimet S.p.A | ITALY |
| Gold | SAXONIA Edelmetalle GmbH | GERMANY |
| Gold | SEMPSA Joyeria Plateria S.A. | SPAIN |
| Gold | Shandong Zhaojin Gold & Silver Refinery Co., Ltd. | CHINA |
| Gold | Sichuan Tianze Precious Metals Co., Ltd. | CHINA |
| Gold | Singway Technology Co., Ltd. | TAIWAN, PROVINCE OF CHINA |
| Gold | SOE Shyolkovsky Factory of Secondary Precious Metals | RUSSIAN FEDERATION |
| Gold | Solar Applied Materials Technology Corp. | TAIWAN, PROVINCE OF CHINA |
8
| Gold | Sumitomo Metal Mining Co., Ltd. | JAPAN |
| Gold | SungEel HiMetal Co., Ltd. | KOREA, REPUBLIC OF |
| Gold | T.C.A S.p.A | ITALY |
| Gold | Tanaka Kikinzoku Kogyo K.K. | JAPAN |
| Gold | The Refinery of Shandong Gold Mining Co., Ltd. | CHINA |
| Gold | Tokuriki Honten Co., Ltd. | JAPAN |
| Gold | Torecom | KOREA, REPUBLIC OF |
| Gold | Umicore Brasil Ltda. | BRAZIL |
| Gold | Umicore Precious Metals Thailand | THAILAND |
| Gold | Umicore S.A. Business Unit Precious Metals Refining | BELGIUM |
| Gold | United Precious Metal Refining, Inc. | UNITED STATES OF AMERICA |
| Gold | Valcambi S.A. | SWITZERLAND |
| Gold | Western Australian Mint (T/a The Perth Mint) | AUSTRALIA |
| Gold | WIELAND Edelmetalle GmbH | GERMANY |
| Gold | Yamakin Co., Ltd. | JAPAN |
| Gold | Yokohama Metal Co., Ltd. | JAPAN |
| Gold | Zhongyuan Gold Smelter of Zhongjin Gold Corporation | CHINA |
| Gold | Gold Refinery of Zijin Mining Group Co., Ltd. | CHINA |
| Tantalum | Asaka Riken Co., Ltd. | JAPAN |
| Tantalum | Changsha South Tantalum Niobium Co., Ltd. | CHINA |
| Tantalum | Guangdong Rising Rare Metals-EO Materials Ltd. | CHINA |
| Tantalum | D Block Metals, LLC | UNITED STATES OF AMERICA |
| Tantalum | Exotech Inc. | UNITED STATES OF AMERICA |
| Tantalum | F&X Electro-Materials Ltd. | CHINA |
| Tantalum | FIR Metals & Resource Ltd. | CHINA |
| Tantalum | Global Advanced Metals Aizu | JAPAN |
| Tantalum | Global Advanced Metals Boyertown | UNITED STATES OF AMERICA |
| Tantalum | Guangdong Zhiyuan New Material Co., Ltd. | CHINA |
| Tantalum | H.C. Starck Co., Ltd. | THAILAND |
| Tantalum | H.C. Starck Tantalum and Niobium GmbH | GERMANY |
| Tantalum | H.C. Starck Hermsdorf GmbH | GERMANY |
| Tantalum | H.C. Starck Inc. | UNITED STATES OF AMERICA |
| Tantalum | H.C. Starck Ltd. | JAPAN |
| Tantalum | H.C. Starck Smelting GmbH & Co. KG | GERMANY |
| Tantalum | Hengyang King Xing Lifeng New Materials Co., Ltd. | CHINA |
| Tantalum | Jiangxi Dinghai Tantalum & Niobium Co., Ltd. | CHINA |
| Tantalum | Jiangxi Tuohong New Raw Material | CHINA |
| Tantalum | Jiujiang Janny New Material Co., Ltd. | CHINA |
| Tantalum | JiuJiang JinXin Nonferrous Metals Co., Ltd. | CHINA |
| Tantalum | Jiujiang Tanbre Co., Ltd. | CHINA |
| Tantalum | Jiujiang Zhongao Tantalum & Niobium Co., Ltd. | CHINA |
| Tantalum | KEMET Blue Metals | MEXICO |
9
| Tantalum | KEMET Blue Powder | UNITED STATES OF AMERICA |
| Tantalum | LSM Brasil S.A. | BRAZIL |
| Tantalum | Metallurgical Products India Pvt., Ltd. | INDIA |
| Tantalum | Mineracao Taboca S.A. | BRAZIL |
| Tantalum | Mitsui Mining and Smelting Co., Ltd. | JAPAN |
| Tantalum | NPM Silmet AS | ESTONIA |
| Tantalum | Ningxia Orient Tantalum Industry Co., Ltd. | CHINA |
| Tantalum | QuantumClean | UNITED STATES OF AMERICA |
| Tantalum | Resind Industria e Comercio Ltda. | BRAZIL |
| Tantalum | RFH Tantalum Smeltery Co., Ltd./Yanling Jincheng Tantalum & Niobium Co., Ltd. | CHINA |
| Tantalum | Solikamsk Magnesium Works OAO | RUSSIAN FEDERATION |
| Tantalum | Taki Chemical Co., Ltd. | JAPAN |
| Tantalum | Telex Metals | UNITED STATES OF AMERICA |
| Tantalum | Ulba Metallurgical Plant JSC | KAZAKHSTAN |
| Tantalum | XinXing HaoRong Electronic Material Co., Ltd. | CHINA |
| Tin | Alpha | UNITED STATES OF AMERICA |
| Tin | Chenzhou Yunxiang Mining and Metallurgy Co., Ltd. | CHINA |
| Tin | Chifeng Dajingzi Tin Industry Co., Ltd. | CHINA |
| Tin | Jiangxi Ketai Advanced Material Co., Ltd. | CHINA |
| Tin | China Tin Group Co., Ltd. | CHINA |
| Tin | CV Ayi Jaya | INDONESIA |
| Tin | CV Dua Sekawan | INDONESIA |
| Tin | CV Gita Pesona | INDONESIA |
| Tin | PT Aries Kencana Sejahtera | INDONESIA |
| Tin | PT Premium Tin Indonesia | INDONESIA |
| Tin | CV Tiga Sekawan | INDONESIA |
| Tin | CV United Smelting | INDONESIA |
| Tin | CV Venus Inti Perkasa | INDONESIA |
| Tin | Dowa | JAPAN |
| Tin | Metallo Spain S.L.U. | SPAIN |
| Tin | EM Vinto | BOLIVIA (PLURINATIONAL STATE OF) |
| Tin | Fenix Metals | POLAND |
| Tin | Gejiu Fengming Metallurgy Chemical Plant | CHINA |
| Tin | Gejiu Jinye Mineral Company | CHINA |
| Tin | Gejiu Non-Ferrous Metal Processing Co., Ltd. | CHINA |
| Tin | Guangdong Hanhe Non-Ferrous Metal Co., Ltd. | CHINA |
| Tin | Guanyang Guida Nonferrous Metal Smelting Plant | CHINA |
| Tin | HuiChang Hill Tin Industry Co., Ltd. | CHINA |
| Tin | Huichang Jinshunda Tin Co., Ltd. | CHINA |
| Tin | Gejiu Kai Meng Industry and Trade LLC | CHINA |
| Tin | Magnu's Minerais Metais e Ligas Ltda. | BRAZIL |
| Tin | Malaysia Smelting Corporation (MSC) | MALAYSIA |
| Tin | Melt Metais e Ligas S.A. | BRAZIL |
10
| Tin | Metallic Resources, Inc. | UNITED STATES OF AMERICA |
| Tin | Metallo Belgium N.V. | BELGIUM |
| Tin | Mineracao Taboca S.A. | BRAZIL |
| Tin | Minsur | PERU |
| Tin | Mitsubishi Materials Corporation | JAPAN |
| Tin | Modeltech Sdn Bhd | MALAYSIA |
| Tin | Jiangxi New Nanshan Technology Ltd. | CHINA |
| Tin | O.M. Manufacturing (Thailand) Co., Ltd. | THAILAND |
| Tin | O.M. Manufacturing Philippines, Inc. | PHILIPPINES |
| Tin | Operaciones Metalurgical S.A. | BOLIVIA (PLURINATIONAL STATE OF) |
| Tin | PT Artha Cipta Langgeng | INDONESIA |
| Tin | PT ATD Makmur Mandiri Jaya | INDONESIA |
| Tin | PT Babel Inti Perkasa | INDONESIA |
| Tin | PT Bangka Prima Tin | INDONESIA |
| Tin | PT Bangka Serumpun | INDONESIA |
| Tin | PT Bangka Tin Industry | INDONESIA |
| Tin | PT Belitung Industri Sejahtera | INDONESIA |
| Tin | PT Bukit Timah | INDONESIA |
| Tin | PT DS Jaya Abadi | INDONESIA |
| Tin | PT Eunindo Usaha Mandiri | INDONESIA |
| Tin | PT Inti Stania Prima | INDONESIA |
| Tin | PT Karimun Mining | INDONESIA |
| Tin | PT Kijang Jaya Mandiri | INDONESIA |
| Tin | PT Lautan Harmonis Sejahtera | INDONESIA |
| Tin | PT Menara Cipta Mulia | INDONESIA |
| Tin | PT Mitra Stania Prima | INDONESIA |
| Tin | PT Panca Mega Persada | INDONESIA |
| Tin | PT Prima Timah Utama | INDONESIA |
| Tin | PT Refined Bangka Tin | INDONESIA |
| Tin | PT Sariwiguna Binasentosa | INDONESIA |
| Tin | PT Stanindo Inti Perkasa | INDONESIA |
| Tin | PT Sukses Inti Makmur | INDONESIA |
| Tin | PT Sumber Jaya Indah | INDONESIA |
| Tin | PT Timah (Persero) Tbk Kundur | INDONESIA |
| Tin | PT Timah (Persero) Tbk Mentok | INDONESIA |
| Tin | PT Tinindo Inter Nusa | INDONESIA |
| Tin | PT Tommy Utama | INDONESIA |
| Tin | Resind Industria e Comercio Ltda. | BRAZIL |
| Tin | Rui Da Hung | TAIWAN, PROVINCE OF CHINA |
| Tin | Soft Metais Ltda. | BRAZIL |
| Tin | Thaisarco | THAILAND |
| Tin | Gejiu Yunxin Nonferrous Electrolysis Co., Ltd. | CHINA |
| Tin | White Solder Metalurgia e Mineracao Ltda. | BRAZIL |
| Tin | Yunnan Chengfeng Non-ferrous Metals Co., Ltd. | CHINA |
| Tin | Yunnan Tin Company Limited | CHINA |
| Tungsten | A.L.M.T. TUNGSTEN Corp. | JAPAN |
11
| Tungsten | ACL Metais Eireli | BRAZIL |
| Tungsten | Asia Tungsten Products Vietnam Ltd. | VIET NAM |
| Tungsten | Chenzhou Diamond Tungsten Products Co., Ltd. | CHINA |
| Tungsten | Chongyi Zhangyuan Tungsten Co., Ltd. | CHINA |
| Tungsten | Fujian Jinxin Tungsten Co., Ltd. | CHINA |
| Tungsten | Ganzhou Huaxing Tungsten Products Co., Ltd. | CHINA |
| Tungsten | Ganzhou Jiangwu Ferrotungsten Co., Ltd. | CHINA |
| Tungsten | Ganzhou Seadragon W & Mo Co., Ltd. | CHINA |
| Tungsten | Global Tungsten & Powders Corp. | UNITED STATES OF AMERICA |
| Tungsten | Guangdong Xianglu Tungsten Co., Ltd. | CHINA |
| Tungsten | H.C. Starck Tungsten GmbH | GERMANY |
| Tungsten | H.C. Starck Smelting GmbH & Co. KG | GERMANY |
| Tungsten | Hunan Chenzhou Mining Co., Ltd. | CHINA |
| Tungsten | Hunan Chuangda Vanadium Tungsten Co., Ltd. Wuji | CHINA |
| Tungsten | Hunan Chunchang Nonferrous Metals Co., Ltd. | CHINA |
| Tungsten | Hydrometallurg, JSC | RUSSIAN FEDERATION |
| Tungsten | Japan New Metals Co., Ltd. | JAPAN |
| Tungsten | Jiangwu H.C. Starck Tungsten Products Co., Ltd. | CHINA |
| Tungsten | Jiangxi Gan Bei Tungsten Co., Ltd. | CHINA |
| Tungsten | Jiangxi Tonggu Non-ferrous Metallurgical & Chemical Co., Ltd. | CHINA |
| Tungsten | Jiangxi Xinsheng Tungsten Industry Co., Ltd. | CHINA |
| Tungsten | Jiangxi Yaosheng Tungsten Co., Ltd. | CHINA |
| Tungsten | Kennametal Fallon | UNITED STATES OF AMERICA |
| Tungsten | Kennametal Huntsville | UNITED STATES OF AMERICA |
| Tungsten | Malipo Haiyu Tungsten Co., Ltd. | CHINA |
| Tungsten | Moliren Ltd. | RUSSIAN FEDERATION |
| Tungsten | Niagara Refining LLC | UNITED STATES OF AMERICA |
| Tungsten | Nui Phao H.C. Starck Tungsten Chemicals Manufacturing LLC | VIETNAM |
| Tungsten | Philippine Chuangxin Industrial Co., Inc. | PHILIPPINES |
| Tungsten | South-East Nonferrous Metal Company Limited of Hengyang City | CHINA |
| Tungsten | Tejing (Vietnam) Tungsten Co., Ltd. | VIETNAM |
| Tungsten | Unecha Refractory metals plant | RUSSIAN FEDERATION |
| Tungsten | Vietnam Youngsun Tungsten Industry Co., Ltd. | VIETNAM |
| Tungsten | Wolfram Bergbau und Hutten AG | AUSTRIA |
| Tungsten | Woltech Korea Co., Ltd. | KOREA, REPUBLIC OF |
| Tungsten | Xiamen Tungsten (H.C.) Co., Ltd. | CHINA |
| Tungsten | Xiamen Tungsten Co., Ltd. | CHINA |
| Tungsten | Xinfeng Huarui Tungsten & Molybdenum New Material Co., Ltd. | CHINA |
| Tungsten | Xinhai Rendan Shaoguan Tungsten Co., Ltd. | CHINA |
12